Logotype for Eris Lifesciences Limited

Eris Lifesciences (ERIS) investor relations material

Eris Lifesciences Q2 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Eris Lifesciences Limited
Q2 25/26 earnings summary12 Nov, 2025

Executive summary

  • Domestic branded formulations revenue grew 10% year-over-year in Q2 FY26, outpacing the Indian pharma market, with consolidated revenue up 7% and PAT up 39% year-over-year.

  • Biocon segment margins improved to 32% in Q2, and DBF EBITDA margin expanded to 37.6%.

  • International business delivered INR 83 crore revenue in Q2, with a 33% margin, though revenue declined 1% year-over-year due to EU-CDMO validation.

  • Significant progress in European CDMO business, with an order book of INR 700-800 crore at Q2 end and first European CDMO order received.

  • Unaudited standalone and consolidated financial results for Q2 and H1 FY26 were approved, with unmodified auditor opinions and key director re-appointments.

Financial highlights

  • Q2 FY26 consolidated revenue: INR 792 crore; H1: INR 1,565 crore.

  • Q2 EBITDA: INR 288 crore; H1 EBITDA: INR 565 crore.

  • Q2 PAT: INR 134 crore, up 39% year-over-year; H1 PAT: INR 260 crore, up 40%.

  • Basic EPS for Q2 FY26 was INR 8.82; cash EPS: INR 13.

  • Interest expense reduced by 17% year-over-year in Q2.

Outlook and guidance

  • Full-year revenue growth visibility at 12%, 50% above expected market growth.

  • EBITDA growth expected at 15% for the year, with margins above 37%.

  • International business revenue guidance for FY26: INR 375-390 crore; long-term targets of INR 700 crore by FY2028 and INR 1,000 crore by FY2030.

  • Net debt-to-EBITDA ratio targeted below 1.5x by December 2026.

  • Ongoing focus on core pharmaceuticals segment and operational optimization.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Eris Lifesciences earnings date

Logotype for Eris Lifesciences Limited
Q3 25/263 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Eris Lifesciences earnings date

Logotype for Eris Lifesciences Limited
Q3 25/263 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Eris Lifesciences Limited is an India-based pharmaceutical company engaged in the development, manufacturing, and marketing of branded formulations. The company focuses on therapeutic areas such as cardiovascular, diabetes, neurology, gastroenterology, and dermatology. It primarily caters to the domestic market, targeting healthcare professionals and patients through its portfolio of prescription medicines. The company is headquartered in Ahmedabad, India, and its shares are listed on the NSE and BSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage